参考文献/References:
［1］中国医师协会介入医师分会．植入式给药装置介入专家共识［J］．中华医学杂志，2019，99：484-489．
［2］ Starkhammar H, Bengtsson M, Gain TB, et al. A new injection portal for brachially inserted central venous catheter. A multicenter study［J］. Med Oncol Tumor Pharmacother, 1990, 7: 281-285.
［3］ Shiono M, Takahashi S, Takahashi M, et al. Current situation regarding central venous port implantation procedures and complications: a questionnaire-based survey of 11,693 implantations in Japan［J］. Int J Clin Oncol, 2016, 21: 1172-1182.
［4］ Li G, Zhang Y, Ma H, et al. Arm port vs chest port: a systematic review and meta-analysis［J］. Cancer Manag Res, 2019, 11: 6099-6112.
［5］ Li Y, Guo J, Zhang Y, et al. Complications from port-a-cath system implantation in adults with malignant tumors: a 10-year single-center retrospective study［J］. J Interv Med, 2022, 5: 15-22.
［6］ Giuseppina AM, Bertoglio S, Biffi R, et al. Management of antithrombotic treatment and bleeding disorders in patients requiring venous access devices: a systematic review and a GAVeCeLT consensus statement［J］. JVA, 2022, 23: 660-671.
［7］ Dawson R. PICC zone insertion method?（ZIM?）:a systematic approach to determine the ideal insertion site for PICCs in the upper arm［J］. JAVA, 2011, 16: 156-165.
［8］ Katsoulas T, Kapritsou M, Alexandrou E, et al. A comparison of 2 venous puncture sites for peripheral implanted ports［J］. J Infus Nurs, 2019, 42: 283-287.
［9］ Forauer AR, Alonzo M. Change in peripherally inserted central catheter tip position with abduction and adduction of the upper extremity［J］. JVIR, 2000, 11: 1315-1318.
［10］ Carvalho BR, Eagar GM. Immediate post-insertion tip migration of peripherally inserted central catheters dependent on arm position and depth of inspiration［J］. J Med Imaging Radiat Oncol, 2018, 62: 324-329.
［11］赵林芳，胡红杰．静脉输液港的植入与管理［M］．北京：人民卫生出版社，2019：47-56．
［12］ Dale M, Higgins A, Carolan-Rees G. Sherlock 3CG? tip confirmation system for placement of peripherally inserted central catheters: a nice medical technology guidance［J］. Appl Health Econ Health Policy, 2016, 14: 41-49.
［13］ Moureau N, Poole S, Murdock M, et al. Central venous catheters in home infusion care:outcomes analysis in 50,470 patients［J］. J Vasc Interventional Radiol, 2002, 13: 1009-1016.
［14］仇晓霞，金光鑫，郭 艳，等．超声导引下上臂完全植入式输液港植入临床应用［J］．介入放射学杂志，2017，26：688-694．
［15］ Busch JD, Herrmann J, Heller F, et al. Follow-up of radiologically totally implanted central venous access ports of the upper arm: long-term complicationsin 127,750 catheter-days［J］. AJR Am J Roentgenol, 2012, 199: 447-452.
［16］ Marcy PY, Magne N, Castadot P, et al. Is radiologic placement of an arm port mandatory in oncology patients? Analysis of a large bi-institutional experience［J］. Cancer, 2007, 110: 2331-2338.
［17］ Amaya-Zuniga WF, Mojica-Manrique V, Cuya-Martinez JC, et al. Arrhythmia during central catheter placement: avoiding complications and increasing optimal tip placement［J］. J Vasc Access, 2021:11297298211054900.
［18］ Elsharkawy H, Lewis BS, Steiger E, et al. Post placement positional atrial fibrillation and peripherally inserted central catheters［J］. Minerva Anestesiol, 2009, 75: 471-474.
［19］ Shi L, Chen H, Yang Y, et al. Application of intracavitary ECG for positioning the totally implantable venous access port in the upper arm of cancer patients［J］. Exp Ther Med, 2022, 24: 477.
［20］ Mori Y, Nagayama S, Kawamura JI, et al. A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute［J］. Int J Clin Oncol, 2016, 21: 474-482.
［21］ Fonseca IY, Krutman M, Nishinari K, et al. Brachial insertion of fully implantable venous catheters for chemotherapy: complications and quality of life assessment in 35 patients［J］. Einstein, 2016, 14: 473-479.
［22］ Mollee P, Jones M, Stackelroth J, et al. Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: a prospective cohort study［J］. J Hosp Infect, 2011, 78: 26-30.
［23］仇晓霞，金光鑫，郭 艳，等. 肿瘤患者上臂植入输液港相关感染发生率及危险因素研究［J］. 上海交通大学学报（医学版），2019，39：1183-1187．
［24］仇晓霞，金光鑫，郭 艳，等. 肿瘤患者上臂植入输液港并发上肢静脉血栓发生率及危险因素［J］. 介入放射学杂志，2019，28：44-48．
［25］徐海萍，周 琴，韩 伟，等. 手臂输液港与胸壁输液港常见并发症的 Meta分析［J］. 中华护理杂志，2018，53：368-374．
［26］ Heil J, Miesbach W, Vogl T, et al. Deep vein thrombosis of the upper extremity［J］. Dtsch Arztebl Int, 2017, 114: 244-249.
［27］ Yacopetti N. Central venous catheter-related thrombosis:a syste- matic review［J］. J Infus Nurs, 2008, 31: 241-248.
［28］吴超君，缪 晶，张昕童，等. 成人输液港堵塞预防与处理的证据总结［J］. 中华护理杂志，2018，53：346-351．
［29］ Qiu XX, Guo Y, Fan HB, et al. Incidence, risk factors and clinical outcomes of peripherally inserted central catheter spontaneous dislodgment in oncology patients: a prospective cohort study［J］. Int J Nurs Stud, 2014, 51: 955-963.
［30］ Wu CY, Fu JY, Feng PH, et al. Risk factors and possible mechanisms of intravenous port catheter migration［J］. Eur J Vasc Endovasc Surg, 2012, 44: 82-87.
［31］中心静脉通路上海协作组. 完全植入式输液港上海专家共识［J］. 介入放射学杂志，2019，28：1123-1128．
［32］ Marcy PY, Figl A, Amoretti N, et al. Arm port implantation in cancer patients［J］. Int J Clin Oncol, 2010, 15: 328-330.
［33］ David V, Christou N, Etienne P, et al. Extravasation of noncytotoxic drugs［J］. Ann Pharmacother, 2020, 54: 804-814.
［34］ Wang YW, Qiu XX. Kinesiophobia and related factors in cancer patients with TIAPs during the long term: a cross-sectional survey［J］. Supportive Care in Cancer, 2022, 30: 4927-4934.
［35］ Li Y, Guo J, Zhang Y, et al. Intravascular treatment for abnormal catheter positioning of port-a-cath system in the subclavian vein: a single-center study［J］. J Interv Med, 2022, 5: 103-110.
［36］许立超，李文涛，陆箴琦. 全程管理是中心静脉通路安全保障［J］. 介入放射学杂志，2017，26：673-675．
［37］ Schiffer CA, Mangu PB, Wade JC, et al. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology Clinical Practice Guideline［J］. J Clin Oncol, 2013, 31: 1357-1370.
［38］ No authors listed. 2021 Infusion therapy standards of practice updates［J］. J Infus Nurs, 2021, 44:189-190.
［39］ Solinas G, Platini F, Trivellato M, et al. Port in oncology practice: 3-monthly locking with normal saline for catheter maintenance, a preliminary report［J］. J Vasc Access, 2017, 18: 325-327.